Asian Phytoceuticals PCLBKK:APCO-R 62 Altman Z-Score is 14.93 as of Jun. 24, 2026, which is 45% below its 10-year median of 27.07. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.46. The stock has 4 warning signs investors should review. Among 1,933 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks better than 95.4% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 15.03 is strong.
Asian Phytoceuticals PCL has a Altman Z-Score of 14.93, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Asian Phytoceuticals PCL's Altman Z-Score or its related term are showing as below:
BKK:APCO-R'
s Altman Z-Score Range Over the Past 10 Years
Min: 14.61 Med: 27.07 Max: 53.97
Current: 15.03
During the past 13 years, Asian Phytoceuticals PCL's highest Altman Z-Score was 53.97. The lowest was 14.61. And the median was 27.07.
Asian Phytoceuticals PCL (BKK:APCO-R) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: Altman Z-Score Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Altman Z-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Altman Z-Score falls into.
Asian Phytoceuticals PCL Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Asian Phytoceuticals PCL (BKK:APCO-R) has a Altman Z-Score of 14.93 as of Jun. 24, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Asian Phytoceuticals PCL and its competitors. This is 45% below median its historical median of 27.07. Over the past decade, Asian Phytoceuticals PCL's Altman Z-Score has ranged from 14.61 to 53.97. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #89 out of 1933 companies in the Consumer Packaged Goods industry, placing it in the top 4.6%.
Is Asian Phytoceuticals PCL's Altman Z-Score too high?
Asian Phytoceuticals PCL's current Altman Z-Score of 14.93 is 45% below median its 10-year median of 27.07. Over the past 10 years, this metric has ranged from a low of 14.61 to a high of 53.97. The Consumer Packaged Goods industry median Altman Z-Score is 2.83. Asian Phytoceuticals PCL's value of 14.93 is 427.6% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #89 out of 1933 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Altman Z-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #89 out of 1933 companies for Altman Z-Score. This places Asian Phytoceuticals PCL in the top 5% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.83. Asian Phytoceuticals PCL's value of 14.93 is 427.6% above this benchmark. Historically, Asian Phytoceuticals PCL's own Altman Z-Score has ranged from 14.61 to 53.97 over the past decade. While the company's 10-year median is 27.07 vs. the industry median of 2.83, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Consumer Packaged Goods company?
The median Altman Z-Score among Consumer Packaged Goods companies is 2.83, based on 1,933 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current Altman Z-Score of 14.93 is 427.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median Altman Z-Score is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current Altman Z-Score is 14.93, which is 45% below median its own 10-year median of 27.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Altman Z-Score of 14.93. The stock's GF Value™ is ฿7.46, compared to a current price of ฿6.27 — trading 15.9% below its estimated fair value. The current Altman Z-Score is 14.93, which is 45% below median its 10-year median of 27.07 and 427.6% above the Consumer Packaged Goods industry median of 2.83. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Altman Z-Score is 14.93 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 15.9% below its estimated GF Value™ of ฿7.46.
Key valuation signals for BKK:APCO-R:
Altman Z-Score: 14.93 (45% below median its 10-year median of 27.07)
GF Value™: ฿7.46 vs. price of ฿6.27 (15.9% below fair value)
Industry Position: 427.6% above the Consumer Packaged Goods median (#89 of 1933)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
